🇺🇸 FDA
Pipeline program

CHIKV VLP vaccine

EBSI-CV-317-007

Phase 3 mab active

Quick answer

CHIKV VLP vaccine for Chikungunya Virus is a Phase 3 program (mab) at Bavarian Nordic A/S with 2 ClinicalTrials.gov record(s).

Program details

Company
Bavarian Nordic A/S
Indication
Chikungunya Virus
Phase
Phase 3
Modality
mab
Status
active

Clinical trials